Crinetics Pharmaceuticals Funding & Investors
Crinetics Pharmaceuticals Inc operates as a clinical stage pharmaceutical company. The Company develops therapeutics for the treatment of endocrine diseases and cancers. Crinetics Pharmaceuticals serves clients in the State of California.
crinetics.comTotal Amount Raised: $1,146,000,000
Crinetics Pharmaceuticals Funding Rounds
Post Ipo Equity
$350,000,000
Post Ipo Equity Investors
Paradigm BioCapital AdvisorsJanus HendersonGordonMD Global InvestmentsDriehaus Capital ManagementFirst Light Asset ManagementEcoR1 CapitalInvusPerceptive AdvisorsRock Springs CapitalAdage Capital ManagementPost Ipo Equity
$350,000,012
Post Ipo Equity
$125,000,000
Post Ipo Equity
$115,100,000
Grant
$3,200,000
Grant Investors
National Institutes of Health (NIH)Post Ipo Equity
$15,000,000
Post Ipo Equity Investors
Frazier ManagementPost Ipo Equity
$75,000,000
Post Ipo Equity Investors
Bain Capital Life SciencesDeep Track CapitalDriehaus Capital ManagementSeries A
$40,000,000
Series A Investors
5am VenturesVersant VenturesVivo CapitalGrant
$2,700,000
Grant Investors
National Institute of Neurological Disorders and Stroke (NINDS)Grant
$1,500,000
Grant
$2,200,000
Grant Investors
National Institutes of Health (NIH)Series B
$63,500,000
Series B Investors
Perceptive AdvisorsVivo CapitalOrbiMed AdvisorsRa Capital Management5am VenturesVersant VenturesGrant
$2,800,000
Grant Investors
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Funding info provided by Diffbot.